R L Wolf1, J Wang, J A Detre, E L Zager, R W Hurst. 1. Department of Radiology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA. Ronald.Wolf@uphs.upenn.edu
Abstract
BACKGROUND AND PURPOSE: A reliable quantitative technique for measuring arteriovenous (AV) shunt in vascular malformations is not currently available. Here, we evaluated the hypothesis that continuous arterial spin-labeled (CASL) perfusion MR imaging can be used to detect and measure AV shunt in patients with arteriovenous malformations (AVMs). MATERIALS AND METHODS: CASL perfusion MR imaging was performed in 7 patients with AVMs. Semiquantitative AV shunt estimates were generated based on a thresholding strategy by using signal-intensity difference (DeltaM) images to avoid potential errors in cerebral blood flow (CBF) calculation related to abnormal transit times and nonphysiologic blood-tissue water exchange in and around the AVMs. The potential for measuring CBF in regions distant from and near the AVM was explored, as was the relationship of CBF changes related to the size of the shunt. RESULTS: In all 7 cases, striking increased intensity was seen on CASL perfusion DeltaM maps in the nidus and venous structures draining the AVM. Shunt estimates ranged from 30% to 0.6%. Mean CBF measurements in structures near the AVMs were not significantly different from the contralateral measurements. However, CBF in adjacent ipsilateral white matter increased relative to the contralateral side as the percent shunt increased (P = .02). Cortical gray matter CBF Delta (contralateral-ipsilateral) values demonstrated the same effect, but the correlation was weak and not significant. Thalamic CBF decreased ipsilaterally with increasing percent AV shunt (P = .01), indicating a possible steal effect. Basal ganglia Delta values showed little change in CBF with the size of the AV shunt. CONCLUSION: CASL perfusion MR imaging can demonstrate AV shunting, providing high lesion conspicuity and a novel means for evaluating AVM physiology.
BACKGROUND AND PURPOSE: A reliable quantitative technique for measuring arteriovenous (AV) shunt in vascular malformations is not currently available. Here, we evaluated the hypothesis that continuous arterial spin-labeled (CASL) perfusion MR imaging can be used to detect and measure AV shunt in patients with arteriovenous malformations (AVMs). MATERIALS AND METHODS: CASL perfusion MR imaging was performed in 7 patients with AVMs. Semiquantitative AV shunt estimates were generated based on a thresholding strategy by using signal-intensity difference (DeltaM) images to avoid potential errors in cerebral blood flow (CBF) calculation related to abnormal transit times and nonphysiologic blood-tissue water exchange in and around the AVMs. The potential for measuring CBF in regions distant from and near the AVM was explored, as was the relationship of CBF changes related to the size of the shunt. RESULTS: In all 7 cases, striking increased intensity was seen on CASL perfusion DeltaM maps in the nidus and venous structures draining the AVM. Shunt estimates ranged from 30% to 0.6%. Mean CBF measurements in structures near the AVMs were not significantly different from the contralateral measurements. However, CBF in adjacent ipsilateral white matter increased relative to the contralateral side as the percent shunt increased (P = .02). Cortical gray matter CBF Delta (contralateral-ipsilateral) values demonstrated the same effect, but the correlation was weak and not significant. Thalamic CBF decreased ipsilaterally with increasing percent AV shunt (P = .01), indicating a possible steal effect. Basal ganglia Delta values showed little change in CBF with the size of the AV shunt. CONCLUSION: CASL perfusion MR imaging can demonstrate AV shunting, providing high lesion conspicuity and a novel means for evaluating AVM physiology.
Authors: C A Mistretta; T M Grist; F R Korosec; R Frayne; D C Peters; Y Mazaheri; T J Carrol Journal: Magn Reson Med Date: 1998-10 Impact factor: 4.668
Authors: M Essig; R Engenhart; M V Knopp; M Bock; J Scharf; J Debus; F Wenz; H Hawighorst; L R Schad; G van Kaick Journal: Magn Reson Imaging Date: 1996 Impact factor: 2.546
Authors: David J Langer; Joon K Song; Yasunari Niimi; Markus Chwajol; Daniel R Lefton; Jonathan L Brisman; Walter Molofsky; Mark J Kupersmith; Alejandro Berenstein Journal: J Neurosurg Date: 2006-01 Impact factor: 5.115
Authors: Lirong Yan; Sumei Wang; Yan Zhuo; Ronald L Wolf; Michael F Stiefel; Jing An; Yongquan Ye; Qian Zhang; Elias R Melhem; Danny J J Wang Journal: Radiology Date: 2010-07 Impact factor: 11.105
Authors: Leonard Sunwoo; Chul-Ho Sohn; Jong Young Lee; Kyung Sik Yi; Tae Jin Yun; Seung Hong Choi; Young Dae Cho; Ji-Hoon Kim; Sun-Won Park; Moon Hee Han; Sun Ha Paek; Yong Hwy Kim; Jin Wook Kim; Hyun-Tai Chung; Dong Gyu Kim Journal: Neuroradiology Date: 2015-04-24 Impact factor: 2.804
Authors: C Wu; S A Ansari; A R Honarmand; P Vakil; M C Hurley; B R Bendok; J Carr; T J Carroll; M Markl Journal: AJNR Am J Neuroradiol Date: 2015-02-26 Impact factor: 3.825
Authors: X Leclerc; O Guillaud; N Reyns; J Hodel; O Outteryck; F Bala; N Bricout; M Bretzner; N Ramdane; J-P Pruvo; L Hacein-Bey; G Kuchcinski Journal: AJNR Am J Neuroradiol Date: 2020-02-06 Impact factor: 3.825